Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality
- PMID: 22367402
- PMCID: PMC3334514
- DOI: 10.1093/carcin/bgs112
Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality
Abstract
Periodontitis, the progressive loss of the alveolar bone around the teeth and the major cause of tooth loss in adults, is due to oral microorganisms, including Porphyromonas gingivalis. Periodontitis is associated with a local overly aggressive immune response and a spectrum of systemic effects, but the role of this condition in orodigestive cancers is unclear. We prospectively examined clinically ascertained periodontitis (N = 12,605) and serum IgG immune response to P.gingivalis (N = 7852) in relation to orodigestive cancer mortality among men and women in the National Health and Nutrition Examination Survey III. A detailed oral health exam was conducted from 1988 to 1994 in survey Phases I and II, whereas serum IgG for P.gingivalis was measured from 1991 to 1994 in Phase II only. One hundred and five orodigestive cancer deaths were ascertained through 31 December 2006. Periodontitis (moderate or severe) was associated with increased orodigestive cancer mortality [relative risks (RR) = 2.28, 95% confidence interval (CI) = 1.17-4.45]; mortality risks also increased with increasing severity of periodontal disease (P trend = 0.01). Periodontitis-associated mortality was in excess for colorectal (RR = 3.58; 95% CI = 1.15-11.16) and possibly for pancreatic cancer (RR = 4.56; 95% CI = 0.93-22.29). Greater serum P.gingivalis IgG tended to be associated overall with increased orodigestive cancer mortality (P trend = 0.06); P.gingivalis-associated excess orodigestive mortality was also found for healthy subjects not exhibiting overt periodontal disease (RR = 2.25; 95% CI = 1.23-4.14). Orodigestive cancer mortality is related to periodontitis and to the periodontal pathogen, P.gingivalis, independent of periodontal disease. Porphyromonas gingivalis is a biomarker for microbe-associated risk of death due to orodigestive cancer.
Figures
Similar articles
-
Possible role of Porphyromonas gingivalis in orodigestive cancers.J Oral Microbiol. 2019 Jan 9;11(1):1563410. doi: 10.1080/20002297.2018.1563410. eCollection 2019. J Oral Microbiol. 2019. PMID: 30671195 Free PMC article. Review.
-
Serum antibody levels against Porphyromonas gingivalis extract and its chromatographic fraction in chronic and aggressive periodontitis.J Int Acad Periodontol. 2008 Apr;10(2):50-8. J Int Acad Periodontol. 2008. PMID: 18564729
-
Evaluation of circulating IgG antibodies against Porphyromonas gingivalis or its gingipains as serological markers of periodontitis and carriage of the bacterium.J Periodontol. 2025 Feb;96(2):119-128. doi: 10.1002/JPER.23-0766. Epub 2024 Jun 17. J Periodontol. 2025. PMID: 38884611 Free PMC article.
-
Antibody reactive with Porphyromonas gingivalis hemagglutinin in chronic and generalized aggressive periodontitis.J Periodontal Res. 2004 Aug;39(4):263-8. doi: 10.1111/j.1600-0765.2004.00735.x. J Periodontal Res. 2004. PMID: 15206920
-
Porphyromonas gingivalis: a potential trigger of neurodegenerative disease.Front Immunol. 2025 Feb 14;16:1482033. doi: 10.3389/fimmu.2025.1482033. eCollection 2025. Front Immunol. 2025. PMID: 40028317 Free PMC article. Review.
Cited by
-
Microbial and metabolomic analysis of gingival crevicular fluid in general chronic periodontitis patients: lessons for a predictive, preventive, and personalized medical approach.EPMA J. 2020 Apr 16;11(2):197-215. doi: 10.1007/s13167-020-00202-5. eCollection 2020 Jun. EPMA J. 2020. PMID: 32547651 Free PMC article.
-
Effect of psychological stress on the oral-gut microbiota and the potential oral-gut-brain axis.Jpn Dent Sci Rev. 2022 Nov;58:365-375. doi: 10.1016/j.jdsr.2022.11.003. Epub 2022 Nov 17. Jpn Dent Sci Rev. 2022. PMID: 36425317 Free PMC article. Review.
-
Subgingival Periopathogens Assessment and Clinical Periodontal Evaluation of Gastric Cancer Patients-A Cross Sectional Pilot Study.Pathogens. 2022 Mar 16;11(3):360. doi: 10.3390/pathogens11030360. Pathogens. 2022. PMID: 35335684 Free PMC article.
-
Possible role of Porphyromonas gingivalis in orodigestive cancers.J Oral Microbiol. 2019 Jan 9;11(1):1563410. doi: 10.1080/20002297.2018.1563410. eCollection 2019. J Oral Microbiol. 2019. PMID: 30671195 Free PMC article. Review.
-
Serum Levels of Interleukin-6 and Titers of Antibodies Against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.Int J Mol Sci. 2019 Jun 4;20(11):2749. doi: 10.3390/ijms20112749. Int J Mol Sci. 2019. PMID: 31167516 Free PMC article.
References
-
- Pihlstrom BL, et al. Periodontal diseases. Lancet. 2005;366:1809–1820. - PubMed
-
- Lamster IB, et al. The relationship of periodontal disease to diseases and disorders at distant sites: communication to health care professionals and patients. J. Am. Dent. Assoc. 2008;139:1389–1397. - PubMed
-
- Pizzo G, et al. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur. J. Intern. Med. 2010;21:496–502. - PubMed
-
- Fitzpatrick SG, et al. The association between periodontal disease and cancer: a review of the literature. J. Dent. 2010;38:83–95. - PubMed